Viewing StudyNCT03505554



Ignite Creation Date: 2024-05-06 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 12:44 PM
Study NCT ID: NCT03505554
Status: RECRUITING
Last Update Posted: 2023-08-07
First Post: 2018-04-06

Brief Title: A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma
Sponsor: University of Milano Bicocca
Organization: University of Milano Bicocca

Organization Data

Organization: University of Milano Bicocca
Class: OTHER
Study ID: CRU3
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Milano Bicocca
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Pfizer INDUSTRY